Ginkgo Bioworks Holdings (DNA) Short-term Investments (2020 - 2025)

Ginkgo Bioworks Holdings' Short-term Investments history runs 5 years deep, the most recent figure standing at $255.4 million for Q4 2025.

• Quarterly Short-term Investments changed N/A year-over-year to $255.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $255.4 million (changed N/A YoY) and the FY2025 annual result came in at $255.4 million, changed N/A from the prior year.
• Short-term Investments was $255.4 million for Q4 2025 at Ginkgo Bioworks Holdings, up from $1.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $255.4 million in Q4 2025 and bottomed at $1.1 million in Q2 2023.
• A 4-year average of $33.0 million and a median of $5.5 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2021 — Short-term Investments gained 12.04% — and 2022, when it slumped 87.38%.
• Ginkgo Bioworks Holdings' Short-term Investments stood at $15.3 million in 2021, then slumped by 87.38% to $1.9 million in 2022, then sank by 43.47% to $1.1 million in 2023, then surged by 23225.84% to $255.4 million in 2025.
• Business Quant data shows DNA's Short-term Investments at $255.4 million in Q4 2025, $1.1 million in Q2 2023, and $1.6 million in Q1 2023.